Asian Spectator

Times Advertising

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

  • Written by PR Newswire Asia - Asian Spectator
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
  • The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance
  • Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unified platform for efficient global commercialization of Alnylam's innovative RNAi technologies

ZUG, Sw...

Magazine

Jejak pengetahuan astronomi Nusantara sejak lebih dari 1000 tahun lalu: Dari candi hingga prasasti kuno

● Astronomi Indonesia telah berkembang sejak abad ke-7 dan ke-8 Masehi, jauh sebelum Observatorium Bosscha berdiri pada 1920.● Pendekatan astro-arkeologi mengungkap bahwa orientasi candi e...

Negara berutang pada pemulung atasi persoalan sampah, sudah saatnya membayar jasa lingkungan mereka

● Pemulung berkontribusi besar mengurangi sampah, terutama dari rumah tangga yang merupakan sumber terbesar.● Meski berjasa, pemulung kerap mendapat stigma negatif dari masyarakat. Negara ...

Algorithms don’t care: how AI worsens the double burden for Indonesia’s female gig workers

Artificial intelligence is often celebrated as the future of work. It is efficient, innovative and neutral. Yet, for many women in Indonesia’s gig economy, AI feels like a source of mounting pre...